ArticleJournal of acquired immune deficiency syndromes (1999)2026
Exploring provider preferences for HIV treatment support packages integrating long-acting injectable antiretroviral therapy in New York Ryan White Part A medical case management programs.
Article in Journal of acquired immune deficiency syndromes (1999), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundUnderstanding the preferences of core HIV medical case management (MCM) program staff for long-acting injectable antiretroviral therapy (LAI ART)-related support services could help integrate those services into MCM programs, thus facilitating uptake of LAI ART and increasing opportunities for viral suppression among clients who have struggled with daily oral ART adherence.
settingNew York City (NYC)-area Ryan White Part A MCM programs.
methodsWe conducted a survey among MCM program administrators, clinicians, and non-clinical direct-service providers (hereafter, "providers") concerning LAI ART adherence supports. The survey included a discrete choice experiment (DCE) and implementation-readiness and choice-motivation questions. We defined four DCE attributes with 2-4 levels each: Type of ART Medication (monthly/bimonthly LAI ART), Service Location and Mode, Support for Clients, and Rewards for Clients. We ran latent class analysis (LCA) to explore hypothesis-free preference heterogeneity.
resultsFrom July 2022-January 2023, 177 providers completed surveys. About half (52%) were aged 40-59, 72% were women, and the plurality (41%) were Latino/a. In the two-group LCA solution, both groups preferred Bimonthly over Monthly LAI ART. Group 1 (n=45) preferred conventional approaches (e.g., clinic-based injections) whereas Group 2 (n=132) preferred more client-centered approaches (e.g., home-based injections). Reported motivations focused on client convenience. Implementation measures indicated endorsement of LAI ART supports.
conclusionsOur implementation science study suggests that NYC-area MCM providers are motivated to facilitate LAI ART access and adherence. More work is needed to understand what LAI ART-related services programs have integrated, track uptake, and ascertain impacts on viral suppression.
Indexed as
Identifiers
42842482What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.